跳至主要内容
临床试验/NCT04318067
NCT04318067招募中4 期

Melatonin - Production and Release in Children and Adolescents With ADHD and Chronic Sleep Problems and Effects of Melatonin on Sleep

Allan Hvolby1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2020年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
80
试验地点
1
主要终点
Sleep onset

研究概览

简要总结

Treatment with melatonin is often initiated on an insufficient basis as it has not been established prior to starting the treatment whether or not the child had delayed release of endogenous melatonin. At the clinic, it has furthermore been observed that the length of time a child experiences an effect of melatonin treatment varies substantially.

In a clinical context, treatment with melatonin is used increasingly (www.Medstat.dk). However, there is no tradition in Denmark for measuring the endogenous melatonin level before initiating such treatment. Hence there is no way of knowing to what extent the sleep problems were indeed caused by delayed melatonin release.

There seem to be no studies on the difference in the effect of melatonin treatment of children and adolescents depending on whether or not they have delayed DLMO. Likewise, there are no studies including adolescents.

As can be seen, it is important to gain more knowledge about the normal release of melatonin, and the release of melatonin in a group of children and adolescents with a variety of psychiatric diagnoses. It is also essential to investigate whether there are any differences in the release of melatonin in children and adolescents with chronic sleep onset problem and children and adolescents who do not have sleep problems.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
6 Years 至 13 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Children aged 6-13 years referred to the child and adolescent psychiatric department for examination/treatment for ADHD
  • Verified Cronical Sleep Problems
  • Measured Dim Light Melatonin Onset

排除标准

  • IQ below 70
  • Autism Disorder
  • Actual or former treated with Melatonin
  • Allergy to melatonin

研究组 & 干预措施

Sleep problems i Attention Deficit Hyperactivity Disorder

Experimental

Children age 6 to 12 years having ADHD and Sleeping problem will be treated with Melatonin 3 mg one a day (before bedtime)

干预措施: Melatonin 3 mg (Drug)

结局指标

主要结局

Sleep onset

时间窗: 6 month

Time where child falls asleep

Sleep onset Latency (SOL)

时间窗: 6 month

How long time does the child use falling asleep after lights out

Total Sleep time

时间窗: 6 month

次要结局

  • Dundee Difficult Times of the Day Scale (D-DTODS)(6 month)
  • Weiss Functional Impairment Rating Scale (WFIRS)(6 month)
  • Attention Deficit Hyperactivity Disorder - Scale Score (ADHD-RS)(6 month)
  • Side effect Rating Scale(6 month)

研究者

发起方
Allan Hvolby
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Allan Hvolby

Principal Investigator, MD, Ph.D

Region of Southern Denmark

研究点 (1)

Loading locations...

相似试验

Melatonin in ADHD and Sleep Problems | 临床试验